Description

Gast Rozen – Vonoprazan is a novel potassium-competitive acid blocker (P-CAB), introduced as a more potent and faster-acting alternative to proton pump inhibitors (PPIs). It is primarily used for acid-related disorders such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and Helicobacter pylori eradication.